about
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics.Simoctocog alfa for the treatment of hemophilia A.Mining ancient proteins for next-generation drugs.Novel therapies and current clinical progress in hemophilia A.Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Emerging drugs for the treatment of hemophilia A and B.
@en
type
label
Emerging drugs for the treatment of hemophilia A and B.
@en
prefLabel
Emerging drugs for the treatment of hemophilia A and B.
@en
P2860
P921
P1476
Emerging drugs for the treatment of hemophilia A and B.
@en
P2093
Ezio Zanon
Massimo Morfini
P2860
P304
P356
10.1080/14728214.2016.1220536
P407
P577
2016-08-22T00:00:00Z